Segment Information (Tables)

3 Months Ended

Mar. 29, 2024

Segment Reporting [Abstract]

Revenue, Gross Profit, Gross Profit Margin, Operating Income (Loss), and Depreciation and Amortization Expenses by Reportable Segment

Revenue, gross profit, gross profit margin, operating income (loss), and depreciation and amortization expenses by reportable segment were as follows (in thousands, except percentage data):

	Three Months Ended
	March 29,		March 31,
Revenue	2024		2023
Precision Medicine and Manufacturing	$	65,234	$	69,528
Medical Solutions		102,452		77,640
Robotics and Automation		63,230		71,958
Total	$	230,916	$	219,126

	Three Months Ended
	March 29,			March 31,
Gross Profit	2024			2023
Precision Medicine and Manufacturing	$	31,784		$	34,333
Medical Solutions		39,391			31,886
Robotics and Automation		30,549			32,815
Unallocated Corporate and Shared Services		(1,308	)		(1,406	)
Total	$	100,416		$	97,628

	Three Months Ended
	March 29,			March 31,
Gross Profit Margin	2024			2023
Precision Medicine and Manufacturing		48.7	%		49.4	%
Medical Solutions		38.4	%		41.1	%
Robotics and Automation		48.3	%		45.6	%
Total		43.5	%		44.6	%

	Three Months Ended
	March 29,			March 31,
Operating Income (Loss)	2024			2023
Precision Medicine and Manufacturing	$	15,744		$	16,684
Medical Solutions		11,989			9,841
Robotics and Automation		12,216			12,000
Unallocated Corporate and Shared Services		(14,342	)		(12,213	)
Total	$	25,607		$	26,312

	Three Months Ended
	March 29,		March 31,
Depreciation and Amortization Expenses	2024		2023
Precision Medicine and Manufacturing	$	2,362	$	2,596
Medical Solutions		6,090		3,973
Robotics and Automation		4,001		4,845
Unallocated Corporate and Shared Services		476		317
Total	$	12,929	$	11,731

Schedule of Geographic Revenue

The Company aggregates geographic revenue based on the customer locations where products are shipped to. Revenue by geography was as follows (in thousands):

	Three Months Ended
	March 29,		March 31,
	2024		2023
United States	$	117,081	$	103,842
Germany		33,181		34,862
Rest of Europe		30,971		29,365
China		17,071		17,798
Rest of Asia-Pacific		27,256		28,111
Other		5,356		5,148
Total	$	230,916	$	219,126

Revenue By End Market

The Company primarily operates in two end markets: the medical market and the advanced industrial market. Revenue by end market was approximately as follows:

	Three Months Ended
	March 29,			March 31,
	2024			2023
Medical		55	%		54	%
Advanced Industrial		45	%		46	%
Total		100	%		100	%